Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Otolaryngology and Head & Neck Surgery
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023

19.07.2023 | Original Article

Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF)

verfasst von: Deepankar Chandrakapure, Kavita Sachdeva, Kajal Agarwal, Amrita Shukla

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to compare the results of injection triamcinolone and hyaluronidase combination with injection Platelet Rich Plasma (PRP) in management of Oral Submucous Fibrosis (OSMF). Present study was carried out in randomly divided two groups of 30 patients each of OSMF who all are presented with chief complain of reduced mouth opening. Group A patients were given 1 ml of injection triamcinolone and hyaluronidase combination. Group B patients received 1 ml of injection Platelet Rich Plasma. Both injections were given intralesionally once a week for 6 weeks. Results of ANOVA shows significant better results in improving mouth opening in group B patients receiving injection Platelet Rich Plasma as a treatment. In Group A, patients shows improvement in Maximum interincisal distance (MIID) of mean 6.51 ± 1.02 mm as compared to the patients in group B shows improvement in MIID of mean 9.53 ± 1.06 mm (p value < 0.05). Treatment of OSMF with injection Platelet Rich Plasma is a novel method and found to be more efficient than treatment with injection triamcinolone and hyaluronidase combination.
Literatur
1.
Babu S, Bhat RV, Kumar PU (1996) A comparative clinicopathological study of oral submucous fibrosis in habitual chewers of pan masala and betel quid. Clin Toxicol 34:317–322
2.
More CB, Rao NR (2019) Proposed clinical definition for oral submucous fibrosis. J Oral Biol Craniofac Res 9:311–314PubMedPubMedCentral
3.
Hughes MW, Chuong CM (2003) A mouthful of epithelial-mesenchymal interactions. J Invest Dermatol 121:7–8
4.
Gupta SC, Singh M, Khanna S, Jain S (2004) Oral submucous fibrosis with its possible effect on eustachian tube functions: a tympanometric study. Ind J Otolaryngol Head Neck Surg 56:183–185
5.
Rajalalitha P, Vali S (2005) Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder. J Oral Pathol Med 34:321–328PubMed
6.
Choudhari SS, Kulkarni DG, Patankar S, Kheur SM, Sarode SC, Sarode GS, Patil S (2018) Angiogenesis and fibrogenesis in oral submucous fibrosis: a viewpoint. J Contemp Dent Pract 19(2):242–245PubMed
7.
Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK (2012) Pathogenesis of oral submucous fibrosis. J Cancer Res Ther 8:199–203PubMed
8.
Lord GA, Lim CK, Warnakulasuriya S, Peters TJ (2002) Chemical and analytical aspects of areca nut. Addict Biol 7:99–102PubMed
9.
Hernandez BY, Zhu X, Goodman MT, Gatewood R, Mendiola P, Quinata K et al (2017) Betel nut chewing, oral premalignant lesions, and the oral microbiome. PLoS ONE 12:e0172196PubMedPubMedCentral
10.
Mathew P, Austin RD, Varghese SS (2014) Estimation and comparison of copper content in raw areca nuts and commercial areca nut products: Implications in increasing prevalence of oral submucous fibrosis (OSMF). J Clin Diagn Res 8:247–249PubMedPubMedCentral
11.
Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quidinduced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 11:646–653PubMed
12.
More C, Shah P, Rao N, Pawar R (2015) Oral submucous fibrosis: an overview with evidence-based management. Int J Oral Health Sci Adv 3:40–49
13.
Ha VK, Kandula S, NingappaChinnannavar S, Rout P, Mishra S, Bajoria AA (2019) Oral submucous fibrosis: correlation of clinical grading to various habit factors. J Int Soc Prevent Communit Dent 9:363–371
14.
Das M, Manjunath C, Srivastava A, Malavika J, Ameena MV (2017) Epidemiology of oral submucous fibrosis: a review. Int J Oral Health Med Res 3:126–129
15.
Eipe N (2005) The chewing of betel quid and oral submucous fibrosis and anesthesia. Anesth Analg 100:1210–1213PubMed
16.
Paymaster JC (1956) Cancer of the buccal mucosa; a clinical study of 650 cases in Indian patients. Cancer 9(3):431–435PubMed
17.
Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM (2007) Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36(1):25–29PubMed
18.
Arakeri G, Patil SG, Aljabab AS, Lin KC, Merkx MA, Gao S et al (2017) Oral submucous fibrosis: an update on pathophysiology of malignant transformation. J Oral Pathol Med 46(6):413–417PubMed
19.
Gupta S, Jawanda MK (2021) Oral submucous fibrosis: An overview of a challenging entity. Ind J Dermatol Venereol Leprol 87:768–777
20.
Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AS, Johnson NW (2020) Oral submucous fibrosis: a contemporary narrative review with a proposed interprofessional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg 49:1–10
21.
More C, Peter R, Nishma G, Chen Y, Rao N (2018) Association of Candida species with oral submucous fibrosis and oral leukoplakia: A case control study. Ann Clin Lab Res 06:248
22.
Gondivkar SM, Gadbail AR, Sarode SC, Gondivkar RS, Patil S, Gaikwad RN, Yuwanati M (2020) Clinical efficacy of mouth exercising devices in oral submucous fibrosis: a systematic review. J Oral Biol Craniofac Res 10:315–320PubMedPubMedCentral
23.
24.
Gupta M, Pachauri A, Singh SK, Ahuja R, Singh P, Mishra SSS (2014) Recent advancements in oral submucous fibrosis management: an overview. Bangladesh J Dent Res Educ 4(2):88–90
25.
Kumar K, Saraswathi TR, Ranganathan K (2007) Oral submucous fibrosis: a clinico-histopathologic study in Chennai. Ind J Dent Res 18:90–95
26.
Laxmipathi G (1980) Hyalase in submucous fibrosis in oral cavity. Jaipur, India, In: 32nd annual conference of the association of otolaryngologists of India
27.
Amable PR, Carias RB, Teixeira MV et al (2013) Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4:67PubMedPubMedCentral
28.
29.
30.
Rozman P, Bolta Z (2007) Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Pannonica Adriat 16:156–165PubMed
31.
More CB, Das S, Patel H, Adalja C, Kamatchi V, Venkatesh R (2012) Proposed clinical classification for oral submucous fibrosis. Oral Oncol 48(3):200–202PubMed
32.
Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y (2017) Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg 8:89–94PubMedPubMedCentral
33.
Rajendran R (2004) Familial occurrence of oral submucous fibrosis: Report of eight families from northern Kerala, south India. Ind J Dent Res 15:139–144
34.
Khan AM, Sheth MS, Purohit RR (2016) Effect of areca nut chewing and maximal mouth opening in school going children in Ahmedabad. Indian J Med Paediatr Oncol 37:239–341PubMedPubMedCentral
35.
Jain A, Saumya T (2019) Oral submucous fibrosis in paediatric patients: A systematic review and protocol for management. Int J Surg Oncol 2019:3497136PubMedPubMedCentral
36.
Shreedevi B, Shaila M, Sreejyothi HK, Gururaj MP (2017) Genotoxic effect of local & commercial areca nut & tobacco products—A review. Int J Health Sci Res 7:326–331
37.
Coman DR, Mccutcheon MA, Zeidman I (1947) Failure of hyaluronidase to increase in invasiveness of neoplasms. Cancer Res 7(6):383–385PubMed
38.
Laxmipathi G. (1980) Hyalase in Submucous Fibrosis in Oral Cavity. Jaipur, India, In: 32nd annual conference of the association of otolaryngologists of India
39.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(6):638–646PubMed
40.
Anitua E (2001) The use of Plasma Rich Growth Factors(PRGF) in oral surgery. Pract Proced Aesthet Dent 13:487–493PubMed
41.
Marx RE (2001) Platelet rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10:225–228PubMed
42.
Whitman DH, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55:1294–1299PubMed
43.
Hydri AS et al (2020) Comparison of triamcinolone versus platelet rich plasma injection for improving trismus in oral submucous fibrosis. J Bahria Univ Med Dental College 10(1):58–62
44.
Manjunath K, Rajaram PC, Saraswathi TR, Sivapathasundharam B, Sabarinath B, Koteeswaran D, Krithika C (2011) Evaluation of oral submucous fibrosis using ultrasonographic technique: a new diagnostic tool. Indian J Dent Res 22:530–536PubMed
45.
46.
Kakar PK, Puri RK, Venkatachalam VP (1985) Oral submucous fibrosis—treatment with hyalase. J Laryngol Otol 99(1):57–60PubMed
47.
James L, Shetty A, Rishi D, Abraham M (2015) Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in Grade III Oral Submucous fibrosis: a retrospective study. J Int Oral Health : JIOH 7:82–85PubMedPubMedCentral
48.
Ahmed N et al (2020) Comparative study between PRP and hyluronidase injection on fibrous site for OSMF. Int J Appl Res 6:256–259
49.
Gopinath D, Hui LM, Veettil SK, Balakrishnan Nair A, Maharajan MK (2022) Comparative efficacy of interventions for the management of oral submucous fibrosis: a systematic review and network meta-analysis. J Pers Med 12(8):1272PubMedPubMedCentral
Metadaten
Titel
Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF)
verfasst von
Deepankar Chandrakapure
Kavita Sachdeva
Kajal Agarwal
Amrita Shukla
Publikationsdatum
19.07.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 4/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-03912-0

Weitere Artikel der Ausgabe 4/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023 Zur Ausgabe

Original Article

The Effect of Combined Auditory Training on Concurrent Sound Segregation in Young old: A Single-Blinded Randomized Clinical Trial

Original Article

Efficacy of Normal Saline Nasal Spray Added to Standard Treatment Regimen of Chronic Rhinosinusitis: A Randomised Controlled Trial

Original Article

Evaluation of the Current Bacterial Pathogens and Antibiogram of Chronic Suppurative Otitis Media in Adults

Clinical Report

Outcomes and Review in Surgery of Lateral Semicircular Canal Dehiscence in Cholesteatomatous Otitis Media: A Case Series

Original Article

High Frequency Tympanometry in Early Infancy and Its Effect on Oto Acoustic Emissions

Clinical Report

A Case Report of Chondromyxoid Fibroma of the Nasal Cavity

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise